Resveratrol is a natural molecule from the polyphenol family, found mainly in the skin of red grapes, red wine, berries, and peanuts. In recent years, resveratrol has received much attention due to laboratory and animal studies that indicated interesting biological properties, including a potential effect on mechanisms related to aging. It is important to clarify from the outset: the high expectations associated with this molecule have not yet been proven in humans, and some clinical trials have yielded disappointing or inconsistent results.

How is resveratrol supposed to affect aging?

Researchers have proposed several biological mechanisms through which resveratrol might contribute to cell protection, but most have been observed mainly in the lab and in animals and have not been fully validated in humans:

1. Activation of Sirtuins (SIRT1): The central hypothesis, on which the enthusiasm was based, is that resveratrol activates the SIRT1 enzyme, which is involved in metabolic regulation and partially mimics the effects of caloric restriction. This hypothesis is scientifically controversial: some researchers argue that the activation in vitro was a byproduct of the measurement method and not a true direct effect.

2. Potential protection against oxidative stress: Free radicals are aggressive molecules that cause damage to cells and tissues. In vitro, resveratrol acts as an antioxidant, but it is unclear to what extent this effect translates into benefit in the human body, mainly due to its low bioavailability (see below).

3. Effect on gene expression: In animals, an effect on the expression of genes related to metabolism and oxidative stress was observed, but translating these findings to humans is still far from established.

4. Mitochondrial function: Mitochondria are the "powerhouses" of the cell and are responsible for energy production. In animal studies, resveratrol has been linked to an increase in the number of mitochondria and an improvement in their function, but here too, these are mainly findings that have not yet been confirmed in humans.

Bioavailability, the main weakness

One of the major problems with resveratrol as a supplement is that it is well absorbed in the intestine but undergoes rapid and extensive breakdown in the liver, so only a tiny amount of the active molecule reaches the bloodstream. This low bioavailability makes it very difficult to achieve concentrations in the body that showed an effect in vitro, and it is one of the main reasons for the gap between promising laboratory results and relatively disappointing results in humans. To bypass this problem, an experimental compound called SRT501 (resveratrol with reduced particle size) was developed, but its clinical development was halted after a trial in myeloma patients found its safety profile to be unacceptable and its efficacy minimal.

What do the studies actually show?

Yeast (2003): The landmark study by Howitz and Sinclair, published in the journal Nature, was conducted on yeast (not mice) and found that resveratrol was the most potent activator of sirtuins among the compounds tested, extending the lifespan of yeast cells by about 60 to 80 percent. This is an important foundational finding, but it is very far from humans.
Mice on a high-calorie diet (2006): The famous study by Baur and Sinclair, also published in Nature, found that resveratrol improved the health and survival of mice fed a high-calorie (obesogenic) diet, reducing their mortality by about 30 percent compared to obese mice that did not receive it. Note: this is a reduction in mortality in mice sick from obesity, not lifespan extension in healthy mice.
Mice on a standard diet (2008): The follow-up study by Pearson and Sinclair, published in the journal Cell Metabolism, found that resveratrol improved various health markers and slowed signs of aging in mice on a standard diet, but it did not extend their lifespan. This is a key finding that is often omitted: in healthy mice, resveratrol did not add years of life.
Humans, vascular function: Systematic reviews and meta-analyses of controlled trials have found that resveratrol may moderately improve measures of vascular function (such as flow-mediated dilation, FMD), mainly in people with cardiometabolic risk factors. However, the results are inconsistent, some trials showed no effect, and the studies are short-term, so it is impossible to infer an effect on aging or life expectancy from them.

So can resveratrol really "reverse age"?

The cautious and honest answer is: it is unknown, and there is currently no proof. Research on resveratrol in the context of aging is still in its early stages, most of the impressive evidence comes from the lab and animals, and human trials have so far been limited, short-term, and sometimes disappointing. The low bioavailability and the failure in clinical development (SRT501) illustrate how long the road from the lab to the pharmacy shelf is. The existing findings are interesting and justify further research, but they in no way establish the claim that resveratrol slows or reverses aging in humans. As always, consult a doctor before taking any supplement, and be wary of sweeping marketing promises.

References:

https://www.nature.com/articles/nature01960

https://www.nature.com/articles/nature05354

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(08)00182-4

https://pmc.ncbi.nlm.nih.gov/articles/PMC8289612/